Enzyme-cleavable prodrug compounds

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 47/48 (2006.01)

Patent

CA 2411660

The prodrug of the invention is a modified form of a therapeutic agent and comprises a therapeutic agent, an oligopeptide, a stabilizing group and, optionally, a linker group. The prodrug is cleavable by the enzyme Thimet oligopeptidase, or TOP. Also disclosed are methods of designing prodrugs by utilizing TOP-cleavage sequences within the conjugate and methods of treating patients with prodrugs of the invention.

Ce promédicament est une forme modifiée d'un agent thérapeutique et comprend un agent thérapeutique, un oligopeptide, un groupe de stabilisation et éventuellement un groupe de liaison. Ce promédicament peut être clivé par la Thimet oligopeptidase, ou TOP. L'invention concerne également des procédés de conception de promédicaments comprenant l'introduction de séquences de clivage par TOP dans le conjugué, ainsi que des traitements comprenant l'administration des promédicaments décrits à des patients.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Enzyme-cleavable prodrug compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Enzyme-cleavable prodrug compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Enzyme-cleavable prodrug compounds will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1554514

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.